
### [MONDO:0003381](http://purl.obolibrary.org/obo/MONDO_0003381)
**Label:** pituitary gland disease

**Subclasses:** [MONDO:0019834](http://purl.obolibrary.org/obo/MONDO_0019834) (pituitary hormone deficiency from meningeal origin), [MONDO:0019835](http://purl.obolibrary.org/obo/MONDO_0019835) (primary hypophysitis), [MONDO:0019832](http://purl.obolibrary.org/obo/MONDO_0019832) (acquired pituitary hormone deficiency), [MONDO:0019833](http://purl.obolibrary.org/obo/MONDO_0019833) (pituitary hormone deficiency from tumoral origin), [MONDO:0016167](http://purl.obolibrary.org/obo/MONDO_0016167) (optic pathway glioma), [MONDO:0010582](http://purl.obolibrary.org/obo/MONDO_0010582) (diabetes insipidus, neurohypophyseal type), [MONDO:0008545](http://purl.obolibrary.org/obo/MONDO_0008545) (thalassemia, beta+, silent Allele), [MONDO:0016042](http://purl.obolibrary.org/obo/MONDO_0016042) (late-onset isolated ACTH deficiency), [MONDO:0009876](http://purl.obolibrary.org/obo/MONDO_0009876) (isolated growth hormone deficiency type IA), [MONDO:0009878](http://purl.obolibrary.org/obo/MONDO_0009878) (pituitary hormone deficiency, combined, 2), [MONDO:0004216](http://purl.obolibrary.org/obo/MONDO_0004216) (pineal region germinoma), [MONDO:0009879](http://purl.obolibrary.org/obo/MONDO_0009879) (short stature due to growth hormone qualitative anomaly), [MONDO:0008428](http://purl.obolibrary.org/obo/MONDO_0008428) (septooptic dysplasia), [MONDO:0006910](http://purl.obolibrary.org/obo/MONDO_0006910) (pituitary-dependent Cushing's disease), [MONDO:0006634](http://purl.obolibrary.org/obo/MONDO_0006634) (pituitary gland acidophil adenoma), [MONDO:0006238](http://purl.obolibrary.org/obo/MONDO_0006238) (growth hormone-producing pituitary gland adenoma), [MONDO:0018907](http://purl.obolibrary.org/obo/MONDO_0018907) (craniopharyngioma), [MONDO:0019838](http://purl.obolibrary.org/obo/MONDO_0019838) (adenohypophysitis), [MONDO:0019839](http://purl.obolibrary.org/obo/MONDO_0019839) (panhypophysitis), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), [MONDO:0011381](http://purl.obolibrary.org/obo/MONDO_0011381) (dominant beta-thalassemia), [MONDO:0008250](http://purl.obolibrary.org/obo/MONDO_0008250) (isolated growth hormone deficiency type II), [MONDO:0016035](http://purl.obolibrary.org/obo/MONDO_0016035) (Nelson syndrome), [MONDO:0002721](http://purl.obolibrary.org/obo/MONDO_0002721) (necrosis of pituitary), [MONDO:0003932](http://purl.obolibrary.org/obo/MONDO_0003932) (childhood optic nerve glioma), [MONDO:0006802](http://purl.obolibrary.org/obo/MONDO_0006802) (inappropriate ADH syndrome), [MONDO:0003931](http://purl.obolibrary.org/obo/MONDO_0003931) (childhood optic tract astrocytoma), [MONDO:0008813](http://purl.obolibrary.org/obo/MONDO_0008813) (arachnoid cyst), [MONDO:0003256](http://purl.obolibrary.org/obo/MONDO_0003256) (neurohypophysis granular cell tumor), [MONDO:0010615](http://purl.obolibrary.org/obo/MONDO_0010615) (isolated growth hormone deficiency type III), [MONDO:0003257](http://purl.obolibrary.org/obo/MONDO_0003257) (posterior pituitary gland neoplasm), [MONDO:0005152](http://purl.obolibrary.org/obo/MONDO_0005152) (hypopituitarism), [MONDO:0007450](http://purl.obolibrary.org/obo/MONDO_0007450) (neurohypophyseal diabetes insipidus), [MONDO:0007052](http://purl.obolibrary.org/obo/MONDO_0007052) (growth hormone secreting pituitary adenoma), [MONDO:0019933](http://purl.obolibrary.org/obo/MONDO_0019933) (acromegaly), [MONDO:0000518](http://purl.obolibrary.org/obo/MONDO_0000518) (sacrum chordoma), [MONDO:0002892](http://purl.obolibrary.org/obo/MONDO_0002892) (skull base chordoma), [MONDO:0006611](http://purl.obolibrary.org/obo/MONDO_0006611) (skin sarcoidosis), [MONDO:0002894](http://purl.obolibrary.org/obo/MONDO_0002894) (spinal chordoma), [MONDO:0018967](http://purl.obolibrary.org/obo/MONDO_0018967) (short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia), [MONDO:0016534](http://purl.obolibrary.org/obo/MONDO_0016534) (infundibulo-neurohypophysitis), [MONDO:0019402](http://purl.obolibrary.org/obo/MONDO_0019402) (beta thalassemia), [MONDO:0006908](http://purl.obolibrary.org/obo/MONDO_0006908) (pituitary apoplexy), [MONDO:0017582](http://purl.obolibrary.org/obo/MONDO_0017582) (pituitary adenocarcinoma (disease)), [MONDO:0002787](http://purl.obolibrary.org/obo/MONDO_0002787) (adamantinous craniopharyngioma), [MONDO:0020479](http://purl.obolibrary.org/obo/MONDO_0020479) (pituitary gigantism), [MONDO:0004447](http://purl.obolibrary.org/obo/MONDO_0004447) (pituitary stalk meningioma), [MONDO:0002788](http://purl.obolibrary.org/obo/MONDO_0002788) (papillary craniopharyngioma), [MONDO:0003234](http://purl.obolibrary.org/obo/MONDO_0003234) (optic nerve astrocytoma), [MONDO:0004201](http://purl.obolibrary.org/obo/MONDO_0004201) (pituitary hypoplasia), [MONDO:0003235](http://purl.obolibrary.org/obo/MONDO_0003235) (optic nerve glioma), [MONDO:0006740](http://purl.obolibrary.org/obo/MONDO_0006740) (empty sella syndrome), [MONDO:0006068](http://purl.obolibrary.org/obo/MONDO_0006068) (ACTH-producing pituitary gland adenoma), [MONDO:0010712](http://purl.obolibrary.org/obo/MONDO_0010712) (panhypopituitarism, X-linked), [MONDO:0019927](http://purl.obolibrary.org/obo/MONDO_0019927) (growth hormone-producing pituitary gland neoplasm), [MONDO:0009050](http://purl.obolibrary.org/obo/MONDO_0009050) (ACTH-secreting pituitary adenoma), [MONDO:0017611](http://purl.obolibrary.org/obo/MONDO_0017611) (pituitary tumor), [MONDO:0021439](http://purl.obolibrary.org/obo/MONDO_0021439) (benign neoplasm of pituitary gland), [MONDO:0001709](http://purl.obolibrary.org/obo/MONDO_0001709) (hypercalcemic sarcoidosis), [MONDO:0001706](http://purl.obolibrary.org/obo/MONDO_0001706) (cerebral sarcoidosis), [MONDO:0001708](http://purl.obolibrary.org/obo/MONDO_0001708) (pulmonary sarcoidosis), [MONDO:0016487](http://purl.obolibrary.org/obo/MONDO_0016487) (beta-thalassemia intermedia), [MONDO:0013099](http://purl.obolibrary.org/obo/MONDO_0013099) (combined pituitary hormone deficiencies, genetic forms), [MONDO:0016486](http://purl.obolibrary.org/obo/MONDO_0016486) (beta-thalassemia major), [MONDO:0001707](http://purl.obolibrary.org/obo/MONDO_0001707) (cardiac sarcoidosis), [MONDO:0021156](http://purl.obolibrary.org/obo/MONDO_0021156) (hypophysitis), [MONDO:0003849](http://purl.obolibrary.org/obo/MONDO_0003849) (clivus chordoma), [MONDO:0003604](http://purl.obolibrary.org/obo/MONDO_0003604) (functioning pituitary gland neoplasm), [MONDO:0019591](http://purl.obolibrary.org/obo/MONDO_0019591) (panhypopituitarism), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0003603](http://purl.obolibrary.org/obo/MONDO_0003603) (non-functioning pituitary gland neoplasm), [MONDO:0001424](http://purl.obolibrary.org/obo/MONDO_0001424) (sarcoid meningitis), [MONDO:0003202](http://purl.obolibrary.org/obo/MONDO_0003202) (pituitary gland basophilic carcinoma), [MONDO:0000050](http://purl.obolibrary.org/obo/MONDO_0000050) (isolated growth hormone deficiency), [MONDO:0004133](http://purl.obolibrary.org/obo/MONDO_0004133) (pituitary gland mixed eosinophil-basophil adenoma), [MONDO:0006673](http://purl.obolibrary.org/obo/MONDO_0006673) (pituitary gland basophil adenoma), [MONDO:0006793](http://purl.obolibrary.org/obo/MONDO_0006793) (hyperpituitarism), [MONDO:0010492](http://purl.obolibrary.org/obo/MONDO_0010492) (pituitary adenoma, growth hormone-secreting, 2), [MONDO:0010252](http://purl.obolibrary.org/obo/MONDO_0010252) (mental retardation, X-linked, with panhypopituitarism), [MONDO:0008454](http://purl.obolibrary.org/obo/MONDO_0008454) (spinal intradural arachnoid cysts), [MONDO:0008978](http://purl.obolibrary.org/obo/MONDO_0008978) (chordoma (disease)), [MONDO:0003850](http://purl.obolibrary.org/obo/MONDO_0003850) (clivus chondroid chordoma), [MONDO:0007011](http://purl.obolibrary.org/obo/MONDO_0007011) (uveoparotid fever), [MONDO:0006042](http://purl.obolibrary.org/obo/MONDO_0006042) (meningeal tuberculosis), [MONDO:0013006](http://purl.obolibrary.org/obo/MONDO_0013006) (isolated growth hormone deficiency type ib), [MONDO:0019614](http://purl.obolibrary.org/obo/MONDO_0019614) (pituitary deficiency due to Rathke's pouch cysts), [MONDO:0019615](http://purl.obolibrary.org/obo/MONDO_0019615) (pituitary dermoid and epidermoid cysts), [MONDO:0019612](http://purl.obolibrary.org/obo/MONDO_0019612) (functioning gonadotropic adenoma), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0019613](http://purl.obolibrary.org/obo/MONDO_0019613) (non-functioning pituitary adenoma), [MONDO:0019611](http://purl.obolibrary.org/obo/MONDO_0019611) (TSH-secreting pituitary adenoma), [MONDO:0003828](http://purl.obolibrary.org/obo/MONDO_0003828) (growth hormone-producing pituitary gland carcinoma), [MONDO:0008720](http://purl.obolibrary.org/obo/MONDO_0008720) (adrenocorticotropic hormone deficiency (disease)), [MONDO:0003429](http://purl.obolibrary.org/obo/MONDO_0003429) (functioning pituitary gland adenoma), [MONDO:0006373](http://purl.obolibrary.org/obo/MONDO_0006373) (pituitary gland adenoma), [MONDO:0013517](http://purl.obolibrary.org/obo/MONDO_0013517) (beta-thalassemia HBB/LCRB), [MONDO:0006372](http://purl.obolibrary.org/obo/MONDO_0006372) (pituicytoma), [MONDO:0013518](http://purl.obolibrary.org/obo/MONDO_0013518) (pituitary hormone deficiency, combined, 6), [MONDO:0019618](http://purl.obolibrary.org/obo/MONDO_0019618) (Sheehan syndrome), [MONDO:0013512](http://purl.obolibrary.org/obo/MONDO_0013512) (hemoglobin H disease), [MONDO:0019617](http://purl.obolibrary.org/obo/MONDO_0019617) (pituitary deficiency due to empty sella turcica syndrome), [MONDO:0019845](http://purl.obolibrary.org/obo/MONDO_0019845) (Iatrogenic or traumatic pituitary deficiency), [MONDO:0017822](http://purl.obolibrary.org/obo/MONDO_0017822) (mixed functioning pituitary adenoma), [MONDO:0019843](http://purl.obolibrary.org/obo/MONDO_0019843) (pituitary hormone deficiency secondary to a granulomatous disease), [MONDO:0019844](http://purl.obolibrary.org/obo/MONDO_0019844) (pituitary hormone deficiency secondary to storage disease), [MONDO:0009880](http://purl.obolibrary.org/obo/MONDO_0009880) (short stature-pituitary and cerebellar defects-small sella turcica syndrome), [MONDO:0019841](http://purl.obolibrary.org/obo/MONDO_0019841) (pituitary hormone defiency from vascular origin), [MONDO:0002109](http://purl.obolibrary.org/obo/MONDO_0002109) (pituitary cancer), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0003837](http://purl.obolibrary.org/obo/MONDO_0003837) (TSH producing pituitary tumor), [MONDO:0003838](http://purl.obolibrary.org/obo/MONDO_0003838) (malignant ACTH producing neoplasm of pituitary gland), [MONDO:0003836](http://purl.obolibrary.org/obo/MONDO_0003836) (malignant thyroid stimulating hormone producing neoplasm of pituitary gland), [MONDO:0001259](http://purl.obolibrary.org/obo/MONDO_0001259) (pituitary infarct), [MONDO:0006701](http://purl.obolibrary.org/obo/MONDO_0006701) (chromophobe adenoma), [MONDO:0003430](http://purl.obolibrary.org/obo/MONDO_0003430) (prolactin producing pituitary tumor), [MONDO:0005696](http://purl.obolibrary.org/obo/MONDO_0005696) (central nervous system tuberculosis), [MONDO:0006388](http://purl.obolibrary.org/obo/MONDO_0006388) (prolactin-producing pituitary gland carcinoma), [MONDO:0006145](http://purl.obolibrary.org/obo/MONDO_0006145) (chondroid chordoma), [MONDO:0009091](http://purl.obolibrary.org/obo/MONDO_0009091) (non-acquired combined pituitary hormone deficiency with spine abnormalities), [MONDO:0017824](http://purl.obolibrary.org/obo/MONDO_0017824) (familial isolated pituitary adenoma), [MONDO:0010911](http://purl.obolibrary.org/obo/MONDO_0010911) (prolactin-producing pituitary gland adenoma), [MONDO:0017823](http://purl.obolibrary.org/obo/MONDO_0017823) (Somatomammotropinoma), [MONDO:0017826](http://purl.obolibrary.org/obo/MONDO_0017826) (null pituitary adenoma), [MONDO:0017825](http://purl.obolibrary.org/obo/MONDO_0017825) (silent pituitary adenoma), 

**Mapped go classes:** [GO:0060124](http://purl.obolibrary.org/obo/GO_0060124) (positive regulation of growth hormone secretion), [GO:0015671](http://purl.obolibrary.org/obo/GO_0015671) (oxygen transport), [GO:0000979](http://purl.obolibrary.org/obo/GO_0000979) (RNA polymerase II core promoter sequence-specific DNA binding), [GO:0008340](http://purl.obolibrary.org/obo/GO_0008340) (determination of adult lifespan), [GO:0007492](http://purl.obolibrary.org/obo/GO_0007492) (endoderm development), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0043584](http://purl.obolibrary.org/obo/GO_0043584) (nose development), [GO:0060009](http://purl.obolibrary.org/obo/GO_0060009) (Sertoli cell development), [GO:0060126](http://purl.obolibrary.org/obo/GO_0060126) (somatotropin secreting cell differentiation), [GO:0000980](http://purl.obolibrary.org/obo/GO_0000980) (RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0031234](http://purl.obolibrary.org/obo/GO_0031234) (extrinsic component of cytoplasmic side of plasma membrane), [GO:0001708](http://purl.obolibrary.org/obo/GO_0001708) (cell fate specification), [GO:0042706](http://purl.obolibrary.org/obo/GO_0042706) (eye photoreceptor cell fate commitment), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0030819](http://purl.obolibrary.org/obo/GO_0030819) (positive regulation of cAMP biosynthetic process), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0005640](http://purl.obolibrary.org/obo/GO_0005640) (nuclear outer membrane), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0001158](http://purl.obolibrary.org/obo/GO_0001158) (enhancer sequence-specific DNA binding), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0005637](http://purl.obolibrary.org/obo/GO_0005637) (nuclear inner membrane), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0030816](http://purl.obolibrary.org/obo/GO_0030816) (positive regulation of cAMP metabolic process), [GO:0030252](http://purl.obolibrary.org/obo/GO_0030252) (growth hormone secretion), [GO:0016520](http://purl.obolibrary.org/obo/GO_0016520) (growth hormone-releasing hormone receptor activity), [GO:0034614](http://purl.obolibrary.org/obo/GO_0034614) (cellular response to reactive oxygen species), [GO:0030492](http://purl.obolibrary.org/obo/GO_0030492) (hemoglobin binding), [GO:0007595](http://purl.obolibrary.org/obo/GO_0007595) (lactation), [GO:0005179](http://purl.obolibrary.org/obo/GO_0005179) (hormone activity), [GO:0009416](http://purl.obolibrary.org/obo/GO_0009416) (response to light stimulus), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0002344](http://purl.obolibrary.org/obo/GO_0002344) (B cell affinity maturation), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0004999](http://purl.obolibrary.org/obo/GO_0004999) (vasoactive intestinal polypeptide receptor activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0070186](http://purl.obolibrary.org/obo/GO_0070186) (growth hormone activity), [GO:0060828](http://purl.obolibrary.org/obo/GO_0060828) (regulation of canonical Wnt signaling pathway), [GO:0001805](http://purl.obolibrary.org/obo/GO_0001805) (positive regulation of type III hypersensitivity), [GO:0017046](http://purl.obolibrary.org/obo/GO_0017046) (peptide hormone binding), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:0060133](http://purl.obolibrary.org/obo/GO_0060133) (somatotropin secreting cell development), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0021526](http://purl.obolibrary.org/obo/GO_0021526) (medial motor column neuron differentiation), [GO:1900042](http://purl.obolibrary.org/obo/GO_1900042) (positive regulation of interleukin-2 secretion), [GO:0021527](http://purl.obolibrary.org/obo/GO_0021527) (spinal cord association neuron differentiation), [GO:0005185](http://purl.obolibrary.org/obo/GO_0005185) (neurohypophyseal hormone activity), [GO:0038083](http://purl.obolibrary.org/obo/GO_0038083) (peptidyl-tyrosine autophosphorylation), [GO:0046887](http://purl.obolibrary.org/obo/GO_0046887) (positive regulation of hormone secretion), [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0007249](http://purl.obolibrary.org/obo/GO_0007249) (I-kappaB kinase/NF-kappaB signaling), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0021520](http://purl.obolibrary.org/obo/GO_0021520) (spinal cord motor neuron cell fate specification), [GO:0021521](http://purl.obolibrary.org/obo/GO_0021521) (ventral spinal cord interneuron specification), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:0030916](http://purl.obolibrary.org/obo/GO_0030916) (otic vesicle formation), [GO:0001812](http://purl.obolibrary.org/obo/GO_0001812) (positive regulation of type I hypersensitivity), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0001818](http://purl.obolibrary.org/obo/GO_0001818) (negative regulation of cytokine production), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0036459](http://purl.obolibrary.org/obo/GO_0036459) (thiol-dependent ubiquitinyl hydrolase activity), [GO:0019838](http://purl.obolibrary.org/obo/GO_0019838) (growth factor binding), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development), [GO:0005547](http://purl.obolibrary.org/obo/GO_0005547) (phosphatidylinositol-3,4,5-trisphosphate binding), [GO:0051169](http://purl.obolibrary.org/obo/GO_0051169) (nuclear transport), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0031838](http://purl.obolibrary.org/obo/GO_0031838) (haptoglobin-hemoglobin complex), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0050996](http://purl.obolibrary.org/obo/GO_0050996) (positive regulation of lipid catabolic process), [GO:0019825](http://purl.obolibrary.org/obo/GO_0019825) (oxygen binding), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0030183](http://purl.obolibrary.org/obo/GO_0030183) (B cell differentiation), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0007188](http://purl.obolibrary.org/obo/GO_0007188) (adenylate cyclase-modulating G-protein coupled receptor signaling pathway), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0007189](http://purl.obolibrary.org/obo/GO_0007189) (adenylate cyclase-activating G-protein coupled receptor signaling pathway), [GO:0043434](http://purl.obolibrary.org/obo/GO_0043434) (response to peptide hormone), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0047485](http://purl.obolibrary.org/obo/GO_0047485) (protein N-terminus binding), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0030178](http://purl.obolibrary.org/obo/GO_0030178) (negative regulation of Wnt signaling pathway), [GO:0050769](http://purl.obolibrary.org/obo/GO_0050769) (positive regulation of neurogenesis), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0043567](http://purl.obolibrary.org/obo/GO_0043567) (regulation of insulin-like growth factor receptor signaling pathway), [GO:0043203](http://purl.obolibrary.org/obo/GO_0043203) (axon hillock), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0048469](http://purl.obolibrary.org/obo/GO_0048469) (cell maturation), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0071226](http://purl.obolibrary.org/obo/GO_0071226) (cellular response to molecule of fungal origin), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0051877](http://purl.obolibrary.org/obo/GO_0051877) (pigment granule aggregation in cell center), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0019933](http://purl.obolibrary.org/obo/GO_0019933) (cAMP-mediated signaling), [GO:0045927](http://purl.obolibrary.org/obo/GO_0045927) (positive regulation of growth), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0033143](http://purl.obolibrary.org/obo/GO_0033143) (regulation of intracellular steroid hormone receptor signaling pathway), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0048515](http://purl.obolibrary.org/obo/GO_0048515) (spermatid differentiation), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0007530](http://purl.obolibrary.org/obo/GO_0007530) (sex determination), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0051246](http://purl.obolibrary.org/obo/GO_0051246) (regulation of protein metabolic process), [GO:0030426](http://purl.obolibrary.org/obo/GO_0030426) (growth cone), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0007405](http://purl.obolibrary.org/obo/GO_0007405) (neuroblast proliferation), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0004935](http://purl.obolibrary.org/obo/GO_0004935) (adrenergic receptor activity), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0008180](http://purl.obolibrary.org/obo/GO_0008180) (COP9 signalosome), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0032962](http://purl.obolibrary.org/obo/GO_0032962) (positive regulation of inositol trisphosphate biosynthetic process), [GO:0010033](http://purl.obolibrary.org/obo/GO_0010033) (response to organic substance), [GO:0034341](http://purl.obolibrary.org/obo/GO_0034341) (response to interferon-gamma), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0007423](http://purl.obolibrary.org/obo/GO_0007423) (sensory organ development), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0071880](http://purl.obolibrary.org/obo/GO_0071880) (adenylate cyclase-activating adrenergic receptor signaling pathway), [GO:0016363](http://purl.obolibrary.org/obo/GO_0016363) (nuclear matrix), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0008045](http://purl.obolibrary.org/obo/GO_0008045) (motor neuron axon guidance), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0090031](http://purl.obolibrary.org/obo/GO_0090031) (positive regulation of steroid hormone biosynthetic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0001890](http://purl.obolibrary.org/obo/GO_0001890) (placenta development), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0040019](http://purl.obolibrary.org/obo/GO_0040019) (positive regulation of embryonic development), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0030889](http://purl.obolibrary.org/obo/GO_0030889) (negative regulation of B cell proliferation), [GO:0048664](http://purl.obolibrary.org/obo/GO_0048664) (neuron fate determination), [GO:0048663](http://purl.obolibrary.org/obo/GO_0048663) (neuron fate commitment), [GO:0051384](http://purl.obolibrary.org/obo/GO_0051384) (response to glucocorticoid), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0007190](http://purl.obolibrary.org/obo/GO_0007190) (activation of adenylate cyclase activity), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0005344](http://purl.obolibrary.org/obo/GO_0005344) (oxygen carrier activity), [GO:0042445](http://purl.obolibrary.org/obo/GO_0042445) (hormone metabolic process), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0046010](http://purl.obolibrary.org/obo/GO_0046010) (positive regulation of circadian sleep/wake cycle, non-REM sleep), [GO:0030879](http://purl.obolibrary.org/obo/GO_0030879) (mammary gland development), [GO:0050860](http://purl.obolibrary.org/obo/GO_0050860) (negative regulation of T cell receptor signaling pathway), [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0071542](http://purl.obolibrary.org/obo/GO_0071542) (dopaminergic neuron differentiation), [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II), [GO:0045165](http://purl.obolibrary.org/obo/GO_0045165) (cell fate commitment), [GO:2000543](http://purl.obolibrary.org/obo/GO_2000543) (positive regulation of gastrulation), [GO:0031721](http://purl.obolibrary.org/obo/GO_0031721) (hemoglobin alpha binding), [GO:0031722](http://purl.obolibrary.org/obo/GO_0031722) (hemoglobin beta binding), [GO:0031720](http://purl.obolibrary.org/obo/GO_0031720) (haptoglobin binding), [GO:0032094](http://purl.obolibrary.org/obo/GO_0032094) (response to food), [GO:0042613](http://purl.obolibrary.org/obo/GO_0042613) (MHC class II protein complex), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0001106](http://purl.obolibrary.org/obo/GO_0001106) (RNA polymerase II transcription corepressor activity), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0001102](http://purl.obolibrary.org/obo/GO_0001102) (RNA polymerase II activating transcription factor binding), [GO:0048286](http://purl.obolibrary.org/obo/GO_0048286) (lung alveolus development), [GO:0001588](http://purl.obolibrary.org/obo/GO_0001588) (dopamine neurotransmitter receptor activity, coupled via Gs), [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0003406](http://purl.obolibrary.org/obo/GO_0003406) (retinal pigment epithelium development), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0032525](http://purl.obolibrary.org/obo/GO_0032525) (somite rostral/caudal axis specification), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0031313](http://purl.obolibrary.org/obo/GO_0031313) (extrinsic component of endosome membrane), [GO:0030104](http://purl.obolibrary.org/obo/GO_0030104) (water homeostasis), [GO:0021984](http://purl.obolibrary.org/obo/GO_0021984) (adenohypophysis development), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0022037](http://purl.obolibrary.org/obo/GO_0022037) (metencephalon development), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0005833](http://purl.obolibrary.org/obo/GO_0005833) (hemoglobin complex), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0048852](http://purl.obolibrary.org/obo/GO_0048852) (diencephalon morphogenesis), [GO:0048850](http://purl.obolibrary.org/obo/GO_0048850) (hypophysis morphogenesis), [GO:0050801](http://purl.obolibrary.org/obo/GO_0050801) (ion homeostasis), [GO:0015758](http://purl.obolibrary.org/obo/GO_0015758) (glucose transport), [GO:0006461](http://purl.obolibrary.org/obo/GO_0006461) (protein complex assembly), [GO:0021978](http://purl.obolibrary.org/obo/GO_0021978) (telencephalon regionalization), [GO:0021979](http://purl.obolibrary.org/obo/GO_0021979) (hypothalamus cell differentiation), [GO:0048856](http://purl.obolibrary.org/obo/GO_0048856) (anatomical structure development), [GO:0005131](http://purl.obolibrary.org/obo/GO_0005131) (growth hormone receptor binding), [GO:0001206](http://purl.obolibrary.org/obo/GO_0001206) (transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0021854](http://purl.obolibrary.org/obo/GO_0021854) (hypothalamus development), [GO:0001205](http://purl.obolibrary.org/obo/GO_0001205) (transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0048732](http://purl.obolibrary.org/obo/GO_0048732) (gland development), [GO:0048853](http://purl.obolibrary.org/obo/GO_0048853) (forebrain morphogenesis), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005802](http://purl.obolibrary.org/obo/GO_0005802) (trans-Golgi network), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0032868](http://purl.obolibrary.org/obo/GO_0032868) (response to insulin), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0004715](http://purl.obolibrary.org/obo/GO_0004715) (non-membrane spanning protein tyrosine kinase activity), [GO:0045595](http://purl.obolibrary.org/obo/GO_0045595) (regulation of cell differentiation), [GO:0097306](http://purl.obolibrary.org/obo/GO_0097306) (cellular response to alcohol), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0002553](http://purl.obolibrary.org/obo/GO_0002553) (histamine secretion by mast cell), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0004601](http://purl.obolibrary.org/obo/GO_0004601) (peroxidase activity), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0098761](http://purl.obolibrary.org/obo/GO_0098761) (cellular response to interleukin-7), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), [GO:0090009](http://purl.obolibrary.org/obo/GO_0090009) (primitive streak formation), 

**Class expressions from DL-Learner:**

- Thing 56.71%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.45%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 50.45%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 35.81%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 35.81%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007068](http://purl.obolibrary.org/obo/GO_0007068) (obsolete negative regulation of transcription during mitotic cell cycle)) 35.81%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007067](http://purl.obolibrary.org/obo/GO_0007067) (null)) 35.81%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007061](http://purl.obolibrary.org/obo/GO_0007061) (null)) 35.81%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007048](http://purl.obolibrary.org/obo/GO_0007048) (obsolete oncogenesis)) 35.81%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007047](http://purl.obolibrary.org/obo/GO_0007047) (null)) 35.81%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007046](http://purl.obolibrary.org/obo/GO_0007046) (null)) 35.81%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007037](http://purl.obolibrary.org/obo/GO_0007037) (null)) 35.81%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007025](http://purl.obolibrary.org/obo/GO_0007025) (null)) 35.81%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007024](http://purl.obolibrary.org/obo/GO_0007024) (null)) 35.81%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0007022](http://purl.obolibrary.org/obo/GO_0007022) (null)) 35.81%


